跳至主要内容
临床试验/NCT02893306
NCT02893306Unknown2 期

Phase 2 Study of Intravenous Administration of Allogeneic Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus.

Universidad del Desarrollo1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2012年3月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
10
试验地点
1
主要终点
Changes in insulin pancreatic reserve

研究概览

简要总结

The purpose of this study is to evaluate whether the administration of multipotent stromal cell also referred as to mesenchymal stem cells (MSCs), modified Type 1 Diabetes progression.

详细描述

Aim: to evaluate whether a single intravenous administration of allogeneic bone marrow-derived multipotent stromal cell also referred as to mesenchymal stem cells (MSCs), modified endogenous insulin secretion capacity and exogenous insulin requirement in patients with Type 1 Diabetes Mellitus.

Participants: 10, females or males, 18 years or older, diagnosed with Type 1 Diabetes Mellitus at most 1 year before enrollment, under exogenous insulin treatment, with pancreatic reserve of insulin.

Intervention: intravenous administration of a single dose (2-3 millions/Kg) of allogeneic MSCs.

Follow up: before and 1, 6, 24 months after MSC administration.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •differential diagnosis of Type 1 Diabetes
  • •diagnosed performed at most 1 year before enrollment
  • •pancreatic reserve of insulin higher than 0.8 nmol/L/h
  • •good general health status
  • •informed consent of patient
  • •consent of treating physician
  • •proved psychiatric competence to be enrolled in a clinical study

排除标准

  • •pregnancy
  • •significant comorbidities
  • •HIV, HBV, HCV, HTLV-1, HLTV-2 or VDRL positive

研究组 & 干预措施

DMT1+MSCs

Experimental

type 1 diabetic patients receiving a single dose of allogeneic ex vivo expanded mesenchymal stem cells

干预措施: MSCs (Biological)

结局指标

主要结局

Changes in insulin pancreatic reserve

时间窗: pre- and 1, 6, 24 months post-intervention

Levels of insulin secreted after the acute ingestion of a protein rich liquid diet

次要结局

  • Changes in insulin requirement(pre- and up to 24 months post-intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paulette Conget

Dr

Universidad del Desarrollo

研究点 (1)

Loading locations...

相似试验